The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
The Association of the Heads of the European Radiological protection Competent Authorities (HERCA) and the Food and Drug Administration (FDA) through its Center for Devices and Radiological Health (CDRH) as part of the U.S. Department of Health and H
At the occasion of its 8th meeting held in Bern on 8 December 2011, HERCA has approved a proposal for a patient release card after a therapeutic application of radionuclides. The card is a complementary document to the document “131I therapy: Patient
At the occasion of its 8th meeting held in Bern on 8 December 2011, HERCA has approved a proposal for a patient release card after a therapeutic application of radionuclides. The card is a complementary document to the document “131I therapy: Patient
Putting patient safety first is a priority for both HERCA, the association of the Heads of European Radiological Protection Competent Authorities and, COCIR, the European trade association representing the medical imaging, electromedical
Putting patient safety first is a priority for both HERCA, the association of the Heads of European Radiological Protection Competent Authorities and, COCIR, the European trade association representing the medical imaging, electromedical
HERCA approves suggestions to include the HERCA proposal on a data system for individual radiological monitoring – in the Outside Workers Directive referred to as a centralised national network and/or individual radiological monitoring documents
HERCA approves suggestions to include the HERCA proposal on a data system for individual radiological monitoring – in the Outside Workers Directive referred to as a centralised national network and/or individual radiological monitoring documents
HERCA, the association of the Heads of European Radiological protection Competent Authorities, approves an interim Statement promoting a consistent European approach to the processes of national assessment and regulatory decisions on the use of